{
    "nctId": "NCT00370240",
    "briefTitle": "Chlorhydrate of Ropivacaine and Breast Cancer Surgery",
    "officialTitle": "Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Pain,Postoperative",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 260,
    "primaryOutcomeMeasure": "Comparing the frequencies of chronic breast pain 3 months after breast surgery evaluated by the Brief Pain Inventory in the two groups.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients treated by conservative surgery with axillary node dissection or treated by mastectomy with or without axillary node dissection or sentinel lymph node biopsy.\n* ASA physical status 1, 2 or 3\n* With a minimum life expectancy of 2 years\n* Written informed consent\n\nExclusion Criteria:\n\n* Any previous cancer other than breast cancer\n* Allergies to local anesthesic and morphine\n* Reported history of drug\n* Pregnancy\n* Homolateral breast surgery during the last 3 years\n* Analgesic use pre-operatively\n* Renal, pulmonary or liver major dysfunction\n* Active malignant disease\n* Unable to follow the protocol for any reason",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}